跳转至内容
Merck
CN
所有图片(1)

文件

20774

Millipore

IHC Select Streptavidin-HRP, prediluted

50 mL IHC Select Streptavidin-HRP, prediluted for IHC(P).

登录查看公司和协议定价


About This Item

UNSPSC代码:
41116010
eCl@ss:
42029053

形式

liquid

包装

pkg of 50 mL

制造商/商品名称

Chemicon®
IHC Select

技术

immunohistochemistry: suitable (paraffin)

检测方法

colorimetric

运输

wet ice

应用

Prediluted for use in Immunohistochemical staining procedures. For example:

Blocking Reagent

Primary Antibody or Negative Control Reagent

Biotinylated Secondary Antibody

Streptavidin-HRP Conjugate

Chromogen

Counterstain

For best results use this conjugate in conjunction with other IHC Select detection reagents. A complete list of reagents is available at www.chemicon.com.

外形

Dropper vial containing Streptavidin conjugated to Horseradish Peroxidase in a ready-to-use format

储存及稳定性

When stored at 2-8°C, this reagent is stable up to the expiration date printed on the label. Do not freeze or expose to elevated temperatures.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

象形图

Exclamation markEnvironment

警示用语:

Warning

危险分类

Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Erika Terzuoli et al.
Cancers, 11(12) (2019-12-11)
Melanoma and non-small-cell lung carcinoma (NSCLC) cell lines are characterized by an intrinsic population of cancer stem-like cells (CSC), and high expression of detoxifying isozymes, the aldehyde dehydrogenases (ALDHs), regulating the redox state. In this study, using melanoma and NSCLC
Ilianna Zoi et al.
Breast cancer research : BCR, 21(1), 132-132 (2019-12-05)
ERBB-2 is overexpressed in about 20% of breast cancers (BCs), indicating poor prognosis. The receptor activator of nuclear factor-κB (RANK) pathway is implicated in ERBB-2 (+) BC. The purpose of this study was to elucidate the underlying molecular mechanism of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门